Skip to main content

Table 2 Least Squares mean percent change from baseline (95% confidence interval) in lipids, lipoproteins and hs-CRP

From: Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects

   LDL-C TC TG HDL-C non-HDL-C Apo B Apo A-I hs-CRP
Non-obese EZ/Simva (n = 77) −25.2 −13.9 −4.8 1.8 −19.9 −16.6 2.0 −7.1
Doubling statin (n = 42) −4.9 −4.1 −5.3 −0.2 −4.8 −5.6 −2.3 −3.7
Rosuva 10 (n = 42) −17.4 −9.4 −2.0 2.6 −13.9 −11.6 1.3 −10.1
Obese EZ/Simva (n = 237) −21.6 −12.7 −6.1 1.2 −17.3 −13.7 −0.4 −1.5
Doubling statin (n = 117) −10.7 −5.3 −0.8 1.8 −8.2 −8.0 0.0 1.1
  Rosuva 10 (n = 249) −20.7 −11.4 −4.2 1.6 −16.1 −12.3 0.6 −9.7